Nitric oxide metabolites in chronic renal failure in consevative and in hemodialysis treatment

Trace Elements and Electrolytes

Volumn 25, Issue 4, 2008, Pages 211-212

  Lo Presti, R ^a   Carollo, C ^a   Montana, M ^a   Vaccaro, F ^a   Caimi, G ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Chronic renal failure; Nitric oxide

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL;

EID: 55349149360     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/tep25211     Document Type: Article

References (5)

1. Blum M, Yachnin T, Wollman Y et al. Low nitric oxide production in patients with chronic renal failure. Nephron. 1998; 79: 265-268.
2. Boger RH, Zoccali C. ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease. Atheroscler. 2003; 4 (Suppl): 23-28.
3. Boger RH, Bode-Roger SM, Szuba A et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998; 98: 1842-1847.
4. Nims RW, Darbyshire JF, Saavedra JE et al. Colorimetric methods for the determination of nitric oxide concentration in neutral acqueous solutions. Methods. 1995; 7: 48-54.
5. Vallance V, Leone A, Calver A et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992; 339: 572-575.